Uncovering a tumor suppressor for triple-negative breast cancers

John Albeck, Joan S. Brugge

Research output: Contribution to journalReview articlepeer-review

18 Scopus citations


"Triple-negative" breast cancers are aggressive malignancies that respond poorly to treatments. Now Sun et al. (2011) find that the activity of the protein tyrosine phosphatase PTPN12 is lost in a large percentage of this breast cancer subtype, offering molecular drivers and possible therapeutic targets for this heterogeneous and intractable cancer.

Original languageEnglish (US)
Pages (from-to)638-640
Number of pages3
Issue number5
StatePublished - Mar 4 2011
Externally publishedYes

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)


Dive into the research topics of 'Uncovering a tumor suppressor for triple-negative breast cancers'. Together they form a unique fingerprint.

Cite this